StockData
Solventum Corp logo

Solventum Corp (SOLV) stock

SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3094% above fair value
$86.06−2.59 (-2.92%)

Close on Nov 17, 2026Market cap $14.65BP/E 96.7Yield –

Solventum operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Solventum's operating cash flow for the twelve months ending Sep 30, 2026 was $310.00M, down 37.1% year over year. For fiscal 2025 it was $369.00M, down 68.9% from the year before.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$369.00M-68.9%
FY2024Dec 31, 2024$1.19B-38.1%
FY2023Dec 31, 2023$1.92B+14.1%
FY2022Dec 31, 2022$1.68B–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$177.00M+132.9%
Q2 FY2026Jun 30, 2026$227.00M+34.3%
Q1 FY2026Mar 31, 2026-$189.00M-751.7%
Q4 FY2025Dec 31, 2025$95.00M-56.6%
Q3 FY2025Sep 30, 2025$76.00M-55.0%
Q2 FY2025Jun 30, 2025$169.00M-52.4%
Q1 FY2025Mar 31, 2025$29.00M-93.4%
Q4 FY2024Dec 31, 2024$219.00M-60.0%
Q3 FY2024Sep 30, 2024$169.00M-65.7%
Q2 FY2024Jun 30, 2024$355.00M-3.0%
Q1 FY2024Mar 31, 2024$442.00M-13.2%
Q4 FY2023Dec 31, 2023$547.00M–
Q3 FY2023Sep 30, 2023$493.00M–
Q2 FY2023Jun 30, 2023$366.00M–
Q1 FY2023Mar 31, 2023$509.00M–

More Solventum figures

See a number that looks wrong?